Emodin potentiates the anti-cancer effects of EGFR inhibitor on pancreatic cancer (PANC-1 and BxPC-3) cells by inhibiting STAT3 signaling, promoting apoptosis. The gene discussed is STAT3; the disease is familial pancreatic carcinoma.